Intensity-modulated radiotherapy
2017-FXY-055-NPC
Unknown other active
Quick answer
Intensity-modulated radiotherapy for Nasopharyngeal Carcinoma is a Unknown program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Nasopharyngeal Carcinoma
- Phase
- Unknown
- Modality
- other
- Status
- active